Alkhalili, Sawsan
Hailemichael, Rahwa
Allen, Cloe
Martin, Sydney A.
Blaszczak, Alecia
Flood, Kelsey S.
Riley, Julia M.
Article History
Received: 30 August 2025
Revised: 30 August 2025
Accepted: 30 October 2025
First Online: 18 November 2025
Declarations
:
: Dr. Julia Riley is an investigator for Abbvie, Novartis and Moonlake Therapeutics. Dr. Kelsey Flood is an investigator for Abbvie, Moonlake, Novartis. She is a consultant for Leo Pharma. She is on the board of directors for the Vulvar Disease Research Consortium. She previously received fellowship funding from Abbvie, the National Psoriasis Foundation and Janssen Biotech, Inc, which was paid directly to her institution.All other authors have no disclosures. Dr. Julia Riley is an investigator for Abbvie, Novartis and Moonlake Therapeutics.Dr. Kelsey Flood is an investigator for Abbvie, Moonlake, Novartis. She is a consultant for Leo Pharma. She is on the board of directors for the Vulvar Disease Research Consortium. She previously received fellowship funding from Abbvie, the National Psoriasis Foundation and Janssen Biotech, Inc, which was paid directly to her institution.